H19 and hyperhomocysteinemia: The lncRNA H19 may participate in the progression of CAD since it is expressed in human atherosclerotic plaques and in a rat model of carotid artery injury [107,108], and that hyperhomocysteinemia, an independent risk factor for CAD, could increase the expression of H19 in aorta and vascular smooth muscle cells [109].